1. Home
  2. CCLD vs STTK Comparison

CCLD vs STTK Comparison

Compare CCLD & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$3.59

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$5.97

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCLD
STTK
Founded
1999
2016
Country
United States
United States
Employees
3650
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
275.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CCLD
STTK
Price
$3.59
$5.97
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$1.50
$7.60
AVG Volume (30 Days)
413.5K
576.6K
Earning Date
01-01-0001
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.02
EPS
N/A
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
$11.92
N/A
Revenue Next Year
$6.37
N/A
P/E Ratio
$32.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$0.69
52 Week High
$4.01
$6.27

Technical Indicators

Market Signals
Indicator
CCLD
STTK
Relative Strength Index (RSI) 81.09 71.91
Support Level $3.23 $1.85
Resistance Level $3.87 N/A
Average True Range (ATR) 0.19 0.41
MACD 0.12 0.12
Stochastic Oscillator 95.38 88.39

Price Performance

Historical Comparison
CCLD
STTK

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: